Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)

NCT01782989 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

286

Enrollment

OTHER

Sponsor class

Conditions

Geographic Atrophy

Interventions

DRUG: ORACEA®
DRUG: Placebo

Sponsor

Paul Yates, MD, PhD

Collaborators

[object Object]